Related Experiment Videos

[Current status of diagnosis and therapy of trophoblast tumors]

G Luschin-Ebengreuth¹, E Petru, H Pickel

¹Geburtshilflich-gynäkologische Universitätsklinik Graz.

Gynakologische Rundschau

|January 1, 1990

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Quality of life in patients with advanced epithelial ovarian cancer (EOC) randomized to maintenance pazopanib or placebo after first-line chemotherapy in the AGO-OVAR 16 trial. Measuring what matters-patient-centered end points in trials of maintenance therapy.

Annals of oncology : official journal of the European Society for Medical Oncology·2017

Topotecan plus carboplatin versus standard therapy with paclitaxel plus carboplatin (PC) or gemcitabine plus carboplatin (GC) or pegylated liposomal doxorubicin plus carboplatin (PLDC): a randomized phase III trial of the NOGGO-AGO-Study Group-AGO Austria and GEICO-ENGOT-GCIG intergroup study (HECTOR).

Annals of oncology : official journal of the European Society for Medical Oncology·2016

Zoledronic acid combined with adjuvant endocrine therapy of tamoxifen versus anastrozol plus ovarian function suppression in premenopausal early breast cancer: final analysis of the Austrian Breast and Colorectal Cancer Study Group Trial 12.

Annals of oncology : official journal of the European Society for Medical Oncology·2014

International multicenter tool to predict the risk of four or more tumor-positive axillary lymph nodes in breast cancer patients with sentinel node macrometastases.

Breast cancer research and treatment·2013

[Peripartum aortic dissection].

Der Anaesthesist·2013

Multicentre validation of different predictive tools of non-sentinel lymph node involvement in breast cancer.

Surgical oncology·2011

See all related articles